Maze Therapeutics, Inc. Common Stock MAZE Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $198.77M-32.5% | $189.25M-3.8% | $316.77M+112% | $264.54M+51.1% | $294.37M+880% | ||
| $153.62M— | $152.67M— | $67.16M— | —— | —— | ||
| $20M— | —— | —— | —— | —— | ||
| $379.78M+26.7% | $349.72M+73.4% | $391.3M— | $271.15M— | $299.71M— | ||
| $4.68M-25.8% | $5.04M-24.4% | $5.54M— | $6.01M— | $6.31M— | ||
| $419.71M+26.1% | $397.13M+65.1% | $422.06M— | $303.52M— | $332.84M— | ||
| $4.01M+66.9% | $1.79M-7.5% | $2.92M+350% | $3.67M+847% | $2.4M+1,089% | ||
| $0— | —— | —— | —— | —— | ||
| $21.24M+14.1% | $22.56M+9.1% | $22.11M— | $19.9M— | $18.62M— | ||
| $38.83M— | —— | —— | —— | —— | ||
| $78.01M+91.3% | $42.16M-3.4% | $42.62M— | $41.28M— | $40.77M— | ||
| $50K+13.6% | $49K+2,350% | $48K— | $44K— | $44K— | ||
| -$513.76M-31.3% | -$489.55M-36.6% | -$454.98M— | -$424.89M— | -$391.21M— | ||
| $341.7M+17.0% | $354.97M+214% | $379.44M— | $262.24M— | $292.07M— | ||
| $419.71M+26.1% | $397.13M+65.1% | $422.06M— | $303.52M— | $332.84M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Maze Therapeutics, Inc. Common Stock's total assets?
- Maze Therapeutics, Inc. Common Stock (MAZE) holds $419.7M in total assets, up 26.1% year over year.
- How much debt does Maze Therapeutics, Inc. Common Stock have?
- Maze Therapeutics, Inc. Common Stock carries $61.2M in total debt against $341.7M of shareholders' equity, a debt-to-equity ratio of 0.18.
- How much cash does Maze Therapeutics, Inc. Common Stock have?
- Maze Therapeutics, Inc. Common Stock holds $198.8M in cash and equivalents.
- Can Maze Therapeutics, Inc. Common Stock cover its short-term obligations?
- Its current ratio is 17.88 — current assets exceed current liabilities.
- Where does Maze Therapeutics, Inc. Common Stock's balance sheet data come from?
- Every line is extracted from Maze Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
